2021Accounting and Corporate ManagementRequires access

Bio-Pharmaceutical Industry R & D Performance Study in China

Jian Yu

Open publisher page 0 citations

Abstract

Bio pharmaceutical industry is a resource-conserving and environment-friendly industry, which is still a new industry in the world. In the process of the development of bio pharmaceutical industry in China, the advantage is the raw material procurement and marketing, the disadvantage is research and development. There are four problems in the research and development of biological medicine industry in China: The shortage of funds, the lack of compound talents, the single source of funds, and the slow development of scientific research. The two models show that the research and development of biological medicine industry in China will have a lagging effect on the development of China's pharmaceutical industry. Four suggestions are put forward: to improve the policy of biological medicine industry, to build a platform for enterprises, to improve the capital market and to train high quality talents.

About this research paper

What this paper is about

Bio pharmaceutical industry is a resource-conserving and environment-friendly industry, which is still a new industry in the world. In the process of the development of bio pharmaceutical industry in China, the advantage is the raw material procurement and marketing, the disadvantage is research and development. There are four problems in the research and development of biological medicine industry in China: The shortage of funds, the lack of compound talents, the single source of funds, and the slow development of scientific research. The two models show that the research and development of biological medicine industry in China will have a lagging effect on the development of China's pharmaceutical industry. Four suggestions are put forward: to improve the policy of biological medicine industry, to build a platform for enterprises, to improve the capital market and to train high quality talents.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Bio pharmaceutical industry is a resource-conserving and environment-friendly industry, which is still a new industry in the world. In the process of the development of bio pharmaceutical industry in China, the advantage is the raw material procurement and marketing, the disadvantage is research and development. There are four problems in the research and development of biological medicine industry in China: The shortage of funds, the lack of compound talents, the single source of funds, and the slow development of scientific research. The two models show that the research and development of biological medicine industry in China will have a lagging effect on the development of China's pharmaceutical industry. Four suggestions are put forward: to improve the policy of biological medicine industry, to build a platform for enterprises, to improve the capital market and to train high quality talents.

Key concepts: Pharmaceutical industry, Lagging, Business, China, Economic shortage, Disadvantage, Quality (philosophy), Resource (disambiguation)

Related papers

Back to paper searchBrowse research topicsOriginal source
Bio-Pharmaceutical Industry R & D Performance Study in China — Research Paper | ScholarLens